Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Times Interest Earned (2021 - 2025)

Canton Strategic Holdings' (CNTN) quarterly Times Interest Earned came in at -$3349.2 in Q4 2025, up 33.43% YoY from -$2510.1 in Q4 2024, and down 1443.46% on a QoQ basis from -$217.0 in Q3 2025.

Analysis

Canton Strategic Holdings (CNTN) Times Interest Earned (2021 - 2025) Analysis & Trends

Canton Strategic Holdings (CNTN) has 5 years of Times Interest Earned data on file, last reported at -$3349.2 in Q4 2025.

  • Quarterly Times Interest Earned rose 33.43% year-over-year to -$3349.2 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$2738.6 (down 279.41% YoY) and the FY2025 annual result came in at -$3.96, down 225.28% from the prior year.
  • Times Interest Earned declined to -$3349.2 in Q4 2025, from -$217.0 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $242.97 in Q3 2022 to a low of -$7150.2 in Q4 2023.
  • A 5-year average of -$1036.6 and a median of -$300.63 in 2025 frame the typical range for Times Interest Earned.
  • Annual changes were most pronounced in 2022 — Times Interest Earned soared 10697.05% — and 2023, when it tumbled 635198.41%.
  • Tracing CNTN's Times Interest Earned over 5 years: stood at -$0.39 in 2021, then jumped by 385.91% to $1.13 in 2022, then plunged by 635198.41% to -$7150.2 in 2023, then gained by 29.63% to -$5031.2 in 2024, then surged by 33.43% to -$3349.2 in 2025.
  • The last three Times Interest Earned figures came in at -$3349.2 (Q4 2025), -$217.0 (Q3 2025), and -$300.46 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,347.13
Sep 30, 2025 -217.00
Jun 30, 2025 -231.88
Mar 31, 2025 -300.63
Dec 31, 2024 -5,075.81
Sep 30, 2024 -1,284.67
Jun 30, 2024 -454.95
Mar 31, 2024 -499.43
Dec 31, 2023 -7,150.16
Sep 30, 2023 -527.77
Jun 30, 2023 -362.84
Mar 31, 2023 -442.23
Dec 31, 2022 201.74
Mar 31, 2022 -0.84
Dec 31, 2021 -0.39
Sep 30, 2021 -2.29
Jun 30, 2021 -5.81
Mar 31, 2021 -9.90